Literature DB >> 28388315

A simulation-based sample size calculation method for pre-clinical tumor xenograft experiments.

Jianrong Wu1, Shengping Yang2.   

Abstract

Pre-clinical tumor xenograft experiments usually require a small sample size that is rarely greater than 20, and data generated from such experiments very often do not have censored observations. Many statistical tests can be used for analyzing such data, but most of them were developed based on large sample approximation. We demonstrate that the type-I error rates of these tests can substantially deviate from the designated rate, especially when the data to be analyzed has a skewed distribution. Consequently, the sample size calculated based on these tests can be erroneous. We propose a modified signed log-likelihood ratio test (MSLRT) to meet the type-I error rate requirement for analyzing pre-clinical tumor xenograft data. The MSLRT has a consistent and symmetric type-I error rate that is very close to the designated rate for a wide range of sample sizes. By simulation, we generated a series of sample size tables based on scenarios commonly expected in tumor xenograft experiments, and we expect that these tables can be used as guidelines for making decisions on the numbers of mice used in tumor xenograft experiments.

Entities:  

Keywords:  Log-normal distribution; modified singed log-likelihood ratio test; pre-clinical; sample size calculation; tumor xenograft experiment

Mesh:

Substances:

Year:  2017        PMID: 28388315      PMCID: PMC6959484          DOI: 10.1080/10543406.2017.1315820

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  8 in total

1.  Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program.

Authors:  E Anders Kolb; Richard Gorlick; John M Maris; Stephen T Keir; Christopher L Morton; Jianrong Wu; Amy W Wozniak; Malcolm A Smith; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2011-05-31       Impact factor: 3.167

2.  Likelihood analysis for the ratio of means of two independent log-normal distributions.

Authors:  Jianrong Wu; Guoyong Jiang; A C M Wong; Xiang Sun
Journal:  Biometrics       Date:  2002-06       Impact factor: 2.571

3.  Likelihood-based confidence intervals for a log-normal mean.

Authors:  Jianrong Wu; A C M Wong; Guoyong Jiang
Journal:  Stat Med       Date:  2003-06-15       Impact factor: 2.373

4.  A simple method for calculating power based on a prior trial.

Authors:  George F Borm; Bastiaan R Bloem; Marten Munneke; Steven Teerenstra
Journal:  J Clin Epidemiol       Date:  2010-06-22       Impact factor: 6.437

5.  Confidence intervals of effect size in randomized comparative parallel-group studies.

Authors:  Jianrong Wu; Guoyong Jiang; Wei Wei
Journal:  Stat Med       Date:  2006-02-28       Impact factor: 2.373

6.  Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis.

Authors:  Brendan Murphy; Han Yin; John M Maris; E Anders Kolb; Richard Gorlick; C Patrick Reynolds; Min H Kang; Stephen T Keir; Raushan T Kurmasheva; Igor Dvorchik; Jianrong Wu; Catherine A Billups; Nana Boateng; Malcolm A Smith; Richard B Lock; Peter J Houghton
Journal:  Cancer Res       Date:  2016-08-05       Impact factor: 12.701

7.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

8.  Assessing cytotoxic treatment effects in preclinical tumor xenograft models.

Authors:  Jianrong Wu; Peter J Houghton
Journal:  J Biopharm Stat       Date:  2009-09       Impact factor: 1.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.